On Invalid Date, Longeveron (NASDAQ: LGVN) reported Q4 2023 earnings per share (EPS) of -$2.50, up 19.05% year over year. Total Longeveron earnings for the quarter were -$6.03 million. In the same quarter last year, Longeveron's earnings per share (EPS) was -$2.10.
As of Q2 2024, Longeveron's earnings has grown year over year. Longeveron's earnings in the past year totalled -$22.21 million.
What is LGVN's earnings date?
Longeveron's earnings date is Invalid Date. Add LGVN to your watchlist to be reminded of LGVN's next earnings announcement.
What was LGVN's revenue last quarter?
On Invalid Date, Longeveron (NASDAQ: LGVN) reported Q4 2023 revenue of $63.00 thousand up 47.93% year over year. In the same quarter last year, Longeveron's revenue was $121.00 thousand.
What was LGVN's revenue growth in the past year?
As of Q2 2024, Longeveron's revenue has grown -41.98% year over year. This is 193.44 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Longeveron's revenue in the past year totalled $709.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.